Literature DB >> 25293555

Thrombocytopenia in pregnancy: do the time of diagnosis and delivery route affect pregnancy outcome in parturients with idiopathic thrombocytopenic purpura?

T Yuce1, D Acar, E Kalafat, A Alkilic, E Cetindag, F Soylemez.   

Abstract

The objective of this study was to investigate the determining effects of diagnosis time on pregnancy outcomes in a population of pregnant women with idiopathic thrombocytopenic purpura (ITP). Records of all the pregnant women with thrombocytopenia were evaluated. Those with a confirmed diagnosis of ITP were included in the study. Main outcome measures were antenatal thrombocyte count, postpartum haemorrhage rate, and route of delivery. Foetal outcomes such as foetal thrombocyte count, haemorrhage, and birth weight were also reported as secondary outcome measures. Time of diagnosis either antenatal or preconception did not significantly alter the investigated parameters. Delivery route had no impact on complication rates. Time of diagnosis also did not affect treatment modality. ITP is rare disorder accounting for less than 5 % of all pregnant thrombocytopenias. Time of diagnosis does not affect maternal-foetal outcomes or treatment modality unless diagnosis is made during labour. Compared to gestational thrombocytopenia, treatment rates may differ but treatment modalities remain the same and the effort put into making the differential should be weighed against maternal stress factors for lengthy laboratory evaluation as long as the thrombocytopenia is of pure nature without any systemic involvement.

Entities:  

Mesh:

Year:  2014        PMID: 25293555     DOI: 10.1007/s12185-014-1688-6

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  8 in total

Review 1.  Idiopathic thrombocytopenic purpura complicating pregnancy.

Authors:  John G Kelton
Journal:  Blood Rev       Date:  2002-03       Impact factor: 8.250

2.  The use of percutaneous umbilical blood sampling in immune thrombocytopenic purpura.

Authors:  A L Scioscia; P A Grannum; J A Copel; J C Hobbins
Journal:  Am J Obstet Gynecol       Date:  1988-11       Impact factor: 8.661

3.  Idiopathic thrombocytopenic purpura in pregnancy: a randomized trial on the effect of antenatal low dose corticosteroids on neonatal platelet count.

Authors:  G C Christiaens; H K Nieuwenhuis; A E von dem Borne; W H Ouwehand; F M Helmerhorst; C M van Dalen; I van der Tweel
Journal:  Br J Obstet Gynaecol       Date:  1990-10

4.  Pregnancy outcome in patients with idiopathic thrombocytopenic purpura.

Authors:  Murali Subbaiah; Sunesh Kumar; Kallol Kumar Roy; Jai Bhagwan Sharma; Neeta Singh
Journal:  Arch Gynecol Obstet       Date:  2013-07-14       Impact factor: 2.344

Review 5.  Management of idiopathic thrombocytopenic purpura in pregnancy.

Authors:  K K Gill; J G Kelton
Journal:  Semin Hematol       Date:  2000-07       Impact factor: 3.851

Review 6.  The risk of spinal haematoma following neuraxial anaesthesia or lumbar puncture in thrombocytopenic individuals.

Authors:  Joost J van Veen; Timothy J Nokes; Mike Makris
Journal:  Br J Haematol       Date:  2009-09-22       Impact factor: 6.998

Review 7.  A retrospective 11-year analysis of obstetric patients with idiopathic thrombocytopenic purpura.

Authors:  Kathryn E Webert; Richa Mittal; Christopher Sigouin; Nancy M Heddle; John G Kelton
Journal:  Blood       Date:  2003-08-28       Impact factor: 22.113

Review 8.  Therapeutic Options for Immune Thrombocytopenia (ITP) During Pregnancy.

Authors:  Anca Nicolescu; Ana Maria Vladareanu; Irina Voican; Minodora Onisai; Radu Vladareanu
Journal:  Maedica (Buchar)       Date:  2013-06
  8 in total
  4 in total

1.  Pregnancy of patients with idiopathic thrombocytopenic purpura: maternal and neonatal outcomes

Authors:  Hakan Kalaycı; Gülşen Doğan Durdağ; Şafak Yılmaz Baran; Seda Yüksel Şimşek; Songül Alemdaroğlu; Serdinç Özdoğan; Esra Bulgan Kılıçdağ
Journal:  J Turk Ger Gynecol Assoc       Date:  2019-08-09

2.  Maternal Resources, Pregnancy Concerns, and Biological Factors Associated to Birth Weight and Psychological Health.

Authors:  David Ramiro-Cortijo; María de la Calle; Andrea Gila-Díaz; Bernardo Moreno-Jiménez; Maria A Martin-Cabrejas; Silvia M Arribas; Eva Garrosa
Journal:  J Clin Med       Date:  2021-02-10       Impact factor: 4.241

3.  Prednisone plus IVIg compared with prednisone or IVIg for immune thrombocytopenia in pregnancy: a national retrospective cohort study.

Authors:  Xiao-Lu Zhu; Ru Feng; Qiu-Sha Huang; Mei-Ying Liang; Ming Jiang; Hui Liu; Yi Liu; Hong-Xia Yao; Lei Zhang; Shen-Xian Qian; Tong-Hua Yang; Jing-Yu Zhang; Xu-Liang Shen; Lin-Hua Yang; Jian-Da Hu; Ren-Wei Huang; Zhong-Xing Jiang; Jing-Wen Wang; Hong-Yu Zhang; Zhen Xiao; Si-Yan Zhan; Hui-Xin Liu; Xing-Lin Wang; Ying-Jun Chang; Yu Wang; Yuan Kong; Lan-Ping Xu; Kai-Yan Liu; Xiao-Hong Zhang; Cheng-Hong Yin; Yue-Ying Li; Qian-Fei Wang; Jian-Liu Wang; Xiao-Jun Huang; Xiao-Hui Zhang
Journal:  Ther Adv Hematol       Date:  2022-04-29

4.  Maternal and fetal outcomes of primary immune thrombocytopenia during pregnancy: A retrospective study.

Authors:  K S Gilmore; C McLintock
Journal:  Obstet Med       Date:  2017-10-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.